Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1081 | 929 | 1131 | 1122 | 1350 | 1681 |
Fund Return | 8.13% | -7.06% | 13.12% | 3.91% | 6.19% | 5.33% |
Place in category | 153 | 754 | 176 | 446 | 502 | 141 |
% in Category | 7 | 33 | 7 | 25 | 33 | 10 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GS India Equity Portfolio Base Acc | 5.14B | 20.47 | 9.44 | 10.10 | ||
GS India Equity Portfolio Base Inc | 5.14B | 20.45 | 9.42 | 10.09 | ||
GS India Equity Portfolio I A Inc | 5.14B | 19.91 | 8.88 | 9.55 | ||
GS India Equity Portfolio I Acc | 5.14B | 21.55 | 10.50 | 11.24 | ||
Goldman Sachs India Equity Portfoli | 5.14B | 21.06 | 10.00 | 10.73 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFSM European Value Fund A1 USD | 2.31B | 2.78 | -2.06 | 5.87 | ||
MFSM European Value Fund I1 USD | 2.31B | 3.41 | -1.15 | 6.90 | ||
MFSM European Value Fund N1 USD | 2.31B | 1.25 | -1.50 | 4.92 | ||
MFSM European Value Fund W1 USD | 2.31B | 2.41 | -0.27 | 6.24 | ||
Europe Equity Plus Fund A perf acc | 2.22B | 11.79 | 6.73 | 5.39 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.34 | 766.7 | -0.42% | |
SAP | DE0007164600 | 3.61 | 240.330 | +0.54% | |
Roche Holding Participation | CH0012032048 | 3.21 | 257.30 | -0.19% | |
Novartis | CH0012005267 | 3.03 | 88.47 | -0.28% | |
Nestle | CH0038863350 | 2.40 | 74.14 | -1.44% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review